These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Quantification of Plasmodium knowlesi versus Plasmodium falciparum in the rhesus liver: implications for malaria vaccine studies in rhesus models. Shears MJ; Seilie AM; Kim Lee Sim B; Hoffman SL; Murphy SC Malar J; 2020 Aug; 19(1):313. PubMed ID: 32867784 [TBL] [Abstract][Full Text] [Related]
25. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. Luke TC; Hoffman SL J Exp Biol; 2003 Nov; 206(Pt 21):3803-8. PubMed ID: 14506215 [TBL] [Abstract][Full Text] [Related]
26. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria. Mo AX; Pesce J; Hall BF Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675 [TBL] [Abstract][Full Text] [Related]
27. Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive Europeans. Mouwenda YD; Jochems SP; Van Unen V; Betouke Ongwe ME; de Steenhuijsen Piters WA; Stam KA; Massinga Loembe M; Sim BKL; Esen M; Hoffman SL; Kremsner PG; Fendel R; Mordmüller B; Yazdanbakhsh M JCI Insight; 2024 May; 9(9):. PubMed ID: 38716733 [TBL] [Abstract][Full Text] [Related]
29. The Development of Whole Sporozoite Vaccines for Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK Front Immunol; 2018; 9():2748. PubMed ID: 30619241 [TBL] [Abstract][Full Text] [Related]
30. Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers. Tumbo AM; Schindler T; Dangy JP; Orlova-Fink N; Bieri JR; Mpina M; Milando FA; Juma O; Hamad A; Nyakarungu E; Chemba M; Mtoro A; Ramadhan K; Olotu A; Makweba D; Mgaya S; Stuart K; Perreau M; Stapleton JT; Jongo S; Hoffman SL; Tanner M; Abdulla S; Daubenberger C Virol J; 2021 Jan; 18(1):28. PubMed ID: 33499880 [TBL] [Abstract][Full Text] [Related]
31. Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation. Tachibana M; Takashima E; Morita M; Sattabongkot J; Ishino T; Culleton R; Torii M; Tsuboi T Parasitol Int; 2022 Apr; 87():102525. PubMed ID: 34896614 [TBL] [Abstract][Full Text] [Related]
34. Caregiver and community perceptions and experiences participating in an infant malaria prevention trial of PfSPZ Vaccine administered by direct venous inoculation: a qualitative study in Siaya County, western Kenya. Achieng F; Rosen JG; Cherop RY; Kariuki S; Hoffman SL; Seder R; Oneko M; Steinhardt LC Malar J; 2020 Jun; 19(1):226. PubMed ID: 32580719 [TBL] [Abstract][Full Text] [Related]
35. A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1. Roestenberg M; Walk J; van der Boor SC; Langenberg MCC; Hoogerwerf MA; Janse JJ; Manurung M; Yap XZ; García AF; Koopman JPR; Meij P; Wessels E; Teelen K; van Waardenburg YM; van de Vegte-Bolmer M; van Gemert GJ; Visser LG; van der Ven AJAM; de Mast Q; Natasha KC; Abebe Y; Murshedkar T; Billingsley PF; Richie TL; Sim BKL; Janse CJ; Hoffman SL; Khan SM; Sauerwein RW Sci Transl Med; 2020 May; 12(544):. PubMed ID: 32434847 [TBL] [Abstract][Full Text] [Related]
36. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Seder RA; Chang LJ; Enama ME; Zephir KL; Sarwar UN; Gordon IJ; Holman LA; James ER; Billingsley PF; Gunasekera A; Richman A; Chakravarty S; Manoj A; Velmurugan S; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Plummer SH; Hendel CS; Novik L; Costner PJ; Mendoza FH; Saunders JG; Nason MC; Richardson JH; Murphy J; Davidson SA; Richie TL; Sedegah M; Sutamihardja A; Fahle GA; Lyke KE; Laurens MB; Roederer M; Tewari K; Epstein JE; Sim BK; Ledgerwood JE; Graham BS; Hoffman SL; Science; 2013 Sep; 341(6152):1359-65. PubMed ID: 23929949 [TBL] [Abstract][Full Text] [Related]
37. Understanding the Liver-Stage Biology of Malaria Parasites: Insights to Enable and Accelerate the Development of a Highly Efficacious Vaccine. Mo AX; McGugan G Am J Trop Med Hyg; 2018 Oct; 99(4):827-832. PubMed ID: 30141395 [TBL] [Abstract][Full Text] [Related]
38. Early whole blood transcriptional responses to radiation-attenuated Plasmodium falciparum sporozoite vaccination in malaria naïve and malaria pre-exposed adult volunteers. Duffy FJ; Du Y; Carnes J; Epstein JE; Hoffman SL; Abdulla S; Jongo S; Mpina M; Daubenberger C; Aitchison JD; Stuart K Malar J; 2021 Jul; 20(1):308. PubMed ID: 34243763 [TBL] [Abstract][Full Text] [Related]
39. Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-escalation, Dose-Escalation, Double-blind, Randomized Controlled Study in Western Kenya. Steinhardt LC; Richie TL; Yego R; Akach D; Hamel MJ; Gutman JR; Wiegand RE; Nzuu EL; Dungani A; Kc N; Murshedkar T; Church LWP; Sim BKL; Billingsley PF; James ER; Abebe Y; Kariuki S; Samuels AM; Otieno K; Sang T; Kachur SP; Styers D; Schlessman K; Abarbanell G; Hoffman SL; Seder RA; Oneko M Clin Infect Dis; 2020 Aug; 71(4):1063-1071. PubMed ID: 31555824 [TBL] [Abstract][Full Text] [Related]
40. Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA. Richie TL; Charoenvit Y; Wang R; Epstein JE; Hedstrom RC; Kumar S; Luke TC; Freilich DA; Aguiar JC; Sacci JB; Sedegah M; Nosek RA; De La Vega P; Berzins MP; Majam VF; Abot EN; Ganeshan H; Richie NO; Banania JG; Baraceros MF; Geter TG; Mere R; Bebris L; Limbach K; Hickey BW; Lanar DE; Ng J; Shi M; Hobart PM; Norman JA; Soisson LA; Hollingdale MR; Rogers WO; Doolan DL; Hoffman SL Hum Vaccin Immunother; 2012 Nov; 8(11):1564-84. PubMed ID: 23151451 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]